Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells

A. Murumagi; A. Hirasawa; S. Khan; M. Arjama; T. Pellinen; R. Koivisto-Korander; A. Leminen; A. Magi; T. Aittokallio; R. Butzow; O. Kallioniemi

Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells

A. Murumagi, A. Hirasawa, S. Khan, M. Arjama, T. Pellinen, R. Koivisto-Korander, A. Leminen, A. Magi, T. Aittokallio, R. Butzow, O. Kallioniemi

Forskningsoutput: Tidskriftsbidrag › Mötesabstrakt › Peer review

Originalspråk	engelska
Tidskrift	International Journal of Gynecological Cancer
Volym	26
Sidor (från-till)	653-653
Antal sidor	1
ISSN	1048-891X
Status	Publicerad - okt 2016
MoE-publikationstyp	Ej behörig

Citera det här

Murumagi, A., Hirasawa, A., Khan, S., Arjama, M., Pellinen, T., Koivisto-Korander, R., Leminen, A., Magi, A., Aittokallio, T., Butzow, R., & Kallioniemi, O. (2016). Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells. International Journal of Gynecological Cancer, 26, 653-653.

Murumagi, A. ; Hirasawa, A. ; Khan, S. ; Arjama, M. ; Pellinen, T. ; Koivisto-Korander, R. ; Leminen, A. ; Magi, A. ; Aittokallio, T. ; Butzow, R. ; Kallioniemi, O. / Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells. I: International Journal of Gynecological Cancer. 2016 ; Vol. 26. s. 653-653.

@article{eacfa814eb514645a52aa91eb3ea4aec,

title = "Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells",

author = "A. Murumagi and A. Hirasawa and S. Khan and M. Arjama and T. Pellinen and R. Koivisto-Korander and A. Leminen and A. Magi and T. Aittokallio and R. Butzow and O. Kallioniemi",

year = "2016",

month = oct,

language = "English",

volume = "26",

pages = "653--653",

journal = "International Journal of Gynecological Cancer",

issn = "1048-891X",

publisher = "BMJ Publishing Group Ltd",

}

Murumagi, A, Hirasawa, A, Khan, S , Arjama, M, Pellinen, T, Koivisto-Korander, R, Leminen, A, Magi, A, Aittokallio, T , Butzow, R & Kallioniemi, O 2016, 'Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells', International Journal of Gynecological Cancer, vol. 26, s. 653-653.

Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells. / Murumagi, A.; Hirasawa, A.; Khan, S.; Arjama, M.; Pellinen, T.; Koivisto-Korander, R.; Leminen, A.; Magi, A.; Aittokallio, T.; Butzow, R.; Kallioniemi, O.

I: International Journal of Gynecological Cancer, Vol. 26, 10.2016, s. 653-653.

Forskningsoutput: Tidskriftsbidrag › Mötesabstrakt › Peer review

TY - JOUR

T1 - Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells

AU - Murumagi, A.

AU - Hirasawa, A.

AU - Khan, S.

AU - Arjama, M.

AU - Pellinen, T.

AU - Koivisto-Korander, R.

AU - Leminen, A.

AU - Magi, A.

AU - Aittokallio, T.

AU - Butzow, R.

AU - Kallioniemi, O.

PY - 2016/10

Y1 - 2016/10

M3 - Meeting Abstract

VL - 26

SP - 653

EP - 653

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

ER -